Skip to content

    Vinati Organics

    VINATIORGAGood
    Chemicals·19 Aug 2024
    Management Summary

    Vinati Organics delivered a strong YoY performance in Q1 FY25 despite sequential margin pressure from rising raw material costs and logistics delays. The company is currently 'sold out' in its flagship ATBS segment, with new capacity slated for FY26. Management remains highly confident in a 20% growth trajectory, backed by a massive ₹800 crore total capex program across ATBS and its niche specialty chemical subsidiary, Veeral Organics.

    Highlights

    8

    • Net income grew 19% YoY to ₹533.98 crores, driven by robust demand in the ATBS segment.

    • PAT increased 24% YoY to ₹86 crores, while EBIT rose 23% to ₹114.8 crores.

    • Management guided for a 20% revenue CAGR over the next three years.

    • Sustainable EBITDA margins are expected to normalize between 26% and 27% from Q2 onwards.

    • Total FY25 capex is projected at ₹570 crores, covering ATBS expansion and the VOPL subsidiary.

    • High-grade ATBS now accounts for over 70% of the product's total volume.

    • Antioxidant (AO) sales are targeted to reach ~50% capacity utilization by the end of FY25.

    • Meaningful revenue contributions from the new MEHQ plant are expected starting in FY26.

    What Changed1

    vs Q4 FY25

    Risks discussed3 → 4 (+1)

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹533.98 Cr+19%YoY
    2. 02EBIT₹114.8 Cr+23%YoY
    3. 03PAT₹86 Cr+24%YoY
    4. 04Sustainable EBITDA Margin26.5%

    Segment breakdown

    Product-wise Revenue Share
    33% ATBS21% Butylphenol & IB Derivatives15% IBB12% IB & HPMTBE8% Antioxidants (AO)4% Customized Products
    List

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    Revenue CAGR
    20%
    		High
    Revenue
    MEHQ Revenue Contribution
    Meaningful
    		High
    Margin
    EBITDA Margin
    26% to 27%
    		High
    Capex
    FY25 Capex Spend
    ₹570 crores
    		High
    Capacity
    Antioxidant Capacity Utilization
    50%
    		Medium

    Risks & concerns

    5
    RiskSeverity

    Logistics and Supply Chain Disruptions

    Increased lead times and tanker unavailability caused inventory to remain in transit during Q1. — Management acknowledged

    medium

    Rising Energy Costs

    Electricity unit prices rose by ~10% and coal prices also saw an uptick, partially offsetting renewable energy benefits. — Both acknowledged

    low

    Stagnant IBB Demand

    Management admitted IBB demand 'remains just as is' due to a languishing API industry. — Analyst acknowledged

    low

    Raw Material Price Volatility

    Q1 margins were hit by RM price increases, though management notes these are typically passed through in contracts. — Management acknowledged

    medium

    Areas of Evasion(1)

    • Specific timeline for R&D-stage niche antioxidants was not provided.

    Q&A highlights

    3

    “The raw material prices increased during Q1... there were a lot of logistics issues... unavailability of tankers. So we had a lot of inventory in transit, which actually reflect a sale in Q2.”

    Explains the temporary dip in margins and confirms that delayed sales will catch up in the subsequent quarter.

    asked by Surya Patra, PhillipCapital

    2 min read5 chapters

    Detailed Narrative

    01

    ATBS Capacity Constraints and High-Grade Shift

    Vinati Organics is currently facing capacity constraints in its flagship ATBS segment, which contributes 33% of revenue. Management noted they are 'sold out' as demand for high-grade ATBS, which now makes up over 70% of volumes, continues to outpace supply. To address this, an expansion project is underway, with commissioning expected in the second half of FY25 and meaningful revenue contributions starting in FY26.

    02

    Margin Normalization and Logistics Headwinds

    Q1 FY25 margins were temporarily suppressed due to a combination of rising raw material costs and logistics bottlenecks, including tanker unavailability. This resulted in higher inventory in transit, which management expects to convert into sales in Q2. Sustainable EBITDA margins are guided at 26-27%, supported by the return of high-margin customized product campaigns typically seen in Q3 and Q4.

    03

    Veeral Organics (VOPL) and MEHQ Commercialization

    The company's 100% owned subsidiary, VOPL, is a key pillar of its growth strategy with a ₹500 crore capex plan. The MEHQ plant is currently on stream and undergoing sampling and yield optimization. While FY25 will see 'meagre' sales from this unit, management expects it to be a significant revenue driver from FY26 onwards, primarily targeting the Chinese export market.

    04

    Antioxidant Business Ramp-up

    Despite a weak global demand environment for antioxidants, Vinati is seeing growth in its AO sales, which reached approximately ₹130 crores in FY24. The company aims to reach 50% capacity utilization by the end of FY25. Furthermore, the R&D pipeline is focused on adding niche antioxidants to the portfolio, which will further diversify the segment's offerings.

    05

    Capex Intensity and Financial Prudence

    The company is in the midst of a heavy investment phase, with a total capex of ₹800 crores (₹300cr for ATBS and ₹500cr for VOPL), of which ₹300cr has already been spent. FY25 capex is pegged at ₹570 crores. Despite this high spend, management reiterated its commitment to a zero-debt policy and a 20% dividend payout ratio, funded by internal accruals and prudent financial management.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.